Wockhardt announced that its novel intravenous antibiotic Foviscu (WCK 4282) has successfully met the primary endpoint in a Phase 3 clinical trial in patients with complicated urinary tract infections ...
The recent study by Tamma and colleagues and another from 2012 [1] provide insight on whether beta-lactam/beta-lactamase-inhibitor combination antibiotics (BLBLIs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results